A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin

NCT04662164 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Not approved by CFDA

Conditions

Type 2 Diabetes Patients

Interventions

DRUG: hepalatide

Sponsor

Shanghai HEP Pharmaceutical Co., Ltd.